Search Results
Found 1 results
510(k) Data Aggregation
(206 days)
Droplet Pen Needles
The Droplet® Pen Needles are intended for use with pen injector device for the subcutaneous injection of insulin.
The Droplet® Pen Needles are sterile, single use needles designed to be used with commercially available pen-injectors for the subcutaneous injection of insulin. Pen needles are used by consumers, caregivers and healthcare professionals. The pen needle assembly consists of a double-ended cannula that is assembled into an injection molded hub using adhesive. The hub has internal threads, which allow it to be screwed onto the pen injector device. This allows the cartridge end of the cannula to penetrate through the rubber septum of the cartridge. The patient end and the cartridge end of the cannula are lubricated using a silicone based lubricant for ease of injection and rubber septum penetration. There is an inner needle shield assembled over the patient end of the cannula to protect the needle point from damage and accidental needle sticks. There is also an outer protective container. Each pen needle assembly is protected with a peel away seal to provide a sterility barrier. To use a pen needle, the user needs to remove the seal, remove the outer protective cap and attach it to the pen injector. Then the user removes the inner protective cap to expose the needle and make an injection. Following the injection the user inserts the used pen needle into the outer cap to remove the pen needle from the pen injector and dispose of it immediately. The pen needle is individually packaged and sterilized with Gamma radiation. It is intended for single use only. Droplet® Pen Needles are available in the following lengths and gauges: 4 mm x 32G, 5 mm x 32G, 6 mm x 32G, 8 mm x 32G, 5 mm x 31G, 6 mm x 31G, 8 mm x 31G, 10 mm x 29G, 12 mm x 29G.
Here's a breakdown of the acceptance criteria and study information for the Droplet® Pen Needles, extracted from the provided text:
1. Table of Acceptance Criteria and Reported Device Performance
Test Parameter | Acceptance Criteria (from ISO 11608-2:2012) | Reported Device Performance |
---|---|---|
Materials | The needle shall be made of tubing materials specified in ISO 9626. | Meets standard |
Dimensions | The needles shall fit the test apparatus specified in item 7.3 of ISO 11608-2. | Meets standard |
Determination of flow rate through the needle | The needle was tested in accordance with Annex A to ISO 11608-2 to determine flow rate through the needle. | Meets standard |
Bond between hub and needle tube | The union of the hub and needle tube shall not break when tested in accordance with Clause 9 of ISO 11608-2. | Meets standard |
Freedom from defects | The needle tube shall fulfill the requirements of ISO 7864, 11.3. | Meets standard |
Lubrication | The needle tube should be lubricated at both the patient end and the cartridge end. The lubricant shall not, under normal or corrected-to-normal vision, be visible as droplets of fluid on the outside surface of the needle tube. | Meets standard |
Dislocation of measuring point at patient end | Dislocation of the cannula point at the patient end shall be in accordance with Table 2 (not provided in this document) below when tested as per Clause 8 (of ISO 11608-2). | Meets standard |
Determination of functional compatibility with needle-based injection systems | Compatibility with any NIS shall be claimed only after testing in accordance with Clause 11. | Meets standard |
Ease of assembly and disassembly | Attachment of the needle shall be possible without removing the needle from its opened unit packaging. Compliance is checked according to the requirements of Clause 11. | Meets standard |
Pre-conditioning of needles | All requirements of the standard related to preconditioning of needles were met. | Meets standard |
Biocompatibility - Cytotoxicity | Based on ISO 10993-1 requirements. | Passed |
Biocompatibility - Sensitization | Based on ISO 10993-1 requirements. | Passed |
Biocompatibility - Intracutaneous Reactivity | Based on ISO 10993-1 requirements. | Passed |
Biocompatibility - Haemocompatibility | Based on ISO 10993-1 requirements. | Passed |
Biocompatibility - System toxicity (acute) | Based on ISO 10993-1 requirements. | Passed |
Biocompatibility - Subchronic toxicity (subacute toxicity) | Based on ISO 10993-1 requirements. | Passed |
Sterility (Gamma Radiation) | To ensure sterility of the device over its shelf life, relevant sterility testing is conducted. (Validated in accordance with ISO 11137-1 to achieve SAL 10-6) | Passed all relevant sterility tests successfully. |
2. Sample Size Used for the Test Set and Data Provenance
The document does not explicitly state the numerical sample sizes used for each specific test in the "Non-Clinical Performance Data" section. It broadly states that "Verification/Validation testing was done according to the requirements of ISO 11608-2:2012 as summarized below. All testing met the applicable requirements." Similarly, for biocompatibility, it states "The selection of biocompatibility tests was made based on the requirements of ISO 10993-1. All the tests have been successfully passed." The sterility testing states "Droplet® Pen Needles have passed all relevant sterility tests successfully."
The data provenance is for a manufacturing company located in Poland (HTL-Strefa S.A.). The data would be considered prospective as it's generated for the purpose of a 510(k) submission, meaning the tests were conducted specifically for this device to demonstrate its performance.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts
This information is not provided in the document. The tests performed are primarily engineering and laboratory-based, adhering to international standards (ISO), rather than relying on human expert assessment for "ground truth" in the way clinical studies or image interpretations might.
4. Adjudication Method for the Test Set
This information is not applicable/not provided. The testing described is objective, standards-based, and performed in a laboratory/technical setting, rather than through expert human adjudication.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
There was no MRMC comparative effectiveness study done. This document describes a medical device (pen needles) that does not involve AI or human readers in an interpretive capacity.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) was done
There was no standalone (algorithm only) performance study done. This device is a physical medical instrument, not a software algorithm.
7. The Type of Ground Truth Used
The ground truth used for the performance data in this submission is based on established international standards and objective measurement criteria. For example:
- Physical and mechanical properties are compared against the specifications in ISO 11608-2:2012 (e.g., materials per ISO 9626, bond strength per Clause 9, freedom from defects per ISO 7864).
- Biocompatibility is evaluated against the requirements of ISO 10993-1.
- Sterility is validated according to ISO 11137-1.
8. The Sample Size for the Training Set
This information is not applicable/not provided. This device is a physical medical product, not an AI/machine learning model that requires a training set.
9. How the Ground Truth for the Training Set Was Established
This information is not applicable/not provided, as there is no training set for this type of device.
Ask a specific question about this device
Page 1 of 1